American Society for Veterinary Clinical Pathology
2424 American Lane
Madison, WI 53704
Telephone: +1-608-443-2479
Fax: +1-608-443-2474
email: info@asvcp.org
1.
Preanalytical Factors Important in Veterinary Clinical Pathology
1.1.
General, including Hematology, Endocrinology, Chemistry and Serology
1.1.1. Specimen Collection, Handling and Transport to the
Laboratory.
Information
concerning sample requirements, proper collection, handling, and delivery or
shipping procedures for any assay performed in the laboratory should be
available to clients electronically, in written materials (such as a laboratory
services manual, special information sheets, journal or newsletter articles),
or by personal telephone conversation. Samples should be collected according to standard practices. Instrument manufacturer's package
inserts have detailed descriptions of appropriate samples, including collection
tubes and handling conditions. The
specifications for sample submission should be provided to the client by each
laboratory. The specimens should be handled carefully and transported to the
laboratory in a timely manner under conditions appropriate for the type of
sample and its stability. Type of
specimen (e.g., whole blood, serum, plasma, urine) should be clearly stated on
the specimen label. Deviation from recommended protocols can adversely affect
test results. Contact manufacturers for specific details.
a. Hematology
i. Blood films
made in the clinic should not be refrigerated and should be protected from
condensation and freezing during transport to the laboratory.
ii. Anticoagulated
samples for hematology that are found to have macroclots that can be found upon
visual inspection will produce variably erroneous results. The clinic should be contacted either
in writing or by phone and informed that the sample will produce erroneous
results. Because the varying degree of inaccuracy can't be predicted, clotted
samples are unsuitable for analysis and it is not recommended that these samples
be analyzed. If samples of
questionable or substandard quality are analyzed, any procedures and possible
inaccuracies should be documented in writing by the laboratory. Additionally, any possibly inaccurate
results should have easily seen comments on the report to the clinician that
clearly state those values may be inaccurate and misleading.
1.1.2. Specimen Identification.
Specimens
should be identified with pertinent information as determined by the
laboratory, such as owner, species, animal signalment, name of clinic or
doctor, address, telephone and fax numbers, e-mail address, location from which
the specimen was collected, etc. Unique and matching identifiers should be
located on both the submission form and container.
1.1.3. Test Identification.
The requested
test(s) should be clearly marked or stated on the submission form.
1.1.4. Specimen Accessioning.
The specimen
information, identification and requested tests should be correctly entered
into the laboratory information system (LIS). Information entered into the LIS may be used to track the
location and appropriate storage of the sample, e.g., immunology vs. hematology
section or frozen vs. refrigerated. Specimen aliquotting and delivery to the appropriate section within the
laboratory or between several departments should be coordinated. Any problems
with sample quality, including but not limited to hemolysis, lipemia, gelling
of the sample, or other analytically significant problems should be recorded
and reported to the clients and laboratory staff. If the degree of inaccuracy associated with sample quality
is likely to be significant, testing should not be performed on the sample in
question and/or results should not be reported. Problems with the reported or unreported
results should be communicated to the client and, if possible, a new sample
obtained.
1.1.5. Client Communication and
Education.
Communication
between laboratory personnel and clients (internal and external) should be
timely and courteous regarding pre-analytical factors influencing laboratory
test results (e.g., incomplete submission forms, inappropriate sample or sample
handling, or poor sample quality). Clients should be informed of the expected
time for receipt of preliminary and final reports. Similarly, feedback from clients to laboratory should be
encouraged. All verbal or written complaints/feedback/suggestions
should be documented and forwarded to the appropriate level of management. Management meetings, etc. must be
documented and organizational reviews conducted to ensure timely and
appropriate follow up on corrective actions.
1.1.6. Personnel Safety.
Conditions
should be comfortable and appropriate for computer entry, data transcription, handling
of specimens, specimen disposal, and all other tasks. Special consideration should be given for repetitive
work. Personal protective
equipment (PPE) should be appropriate for handling specimens and operating
equipment in all areas of the clinical laboratory. Safety procedures for the disposal of all samples, waste,
and other supplies should be appropriate for the type of material. Personnel should receive safety and
biohazard training regarding exposure to potentially hazardous chemicals or
infectious pathogens present in biological materials. Documentation of environmental, health and safety training
should be available and readily accessible for each staff member. Training
should include basic prevention of bacterial contamination as well as information
on zoonotic diseases. All training
should be documented.
1.1.7. Laboratory Environment.
The laboratory
environment should meet standard requirements necessary for safe, rapid,
efficient and effective performance. The workspace should be well-lit and organized in order to promote
efficiency and safety. Equipment and instrumentation should be in working order. Up-to-date
procedure protocols should be easily accessible for reference when needed.
Laboratory facilities and operation should be in compliance with appropriate
government agencies.
1.1.8. Personnel Requirements.
Personnel
should meet training requirements as indicated for specific areas of the
laboratory. Training, continuing
education, and recertification for specialized tasks should be regularly
scheduled and documented. The
laboratory should be staffed appropriately to meet the workload.
1.1.9.
Laboratory Information Systems (LIS).
LIS are intended to improve work-flow and
efficiency of the laboratory. Prior to implementation, a LIS should be
thoroughly evaluated, and the ability to maintain accurate records
verified. Inefficient and unwieldy
LIS should be updated or enhanced based on the needs of the laboratory. LIS should meet all governing legal
regulations for medical record archives. Problems with sample accessioning or archival storage should be
corrected immediately.
1.1.10.
Identification of out-sourced tests ("send-outs").
Clients should be informed of those tests
that are referred to other laboratories.
1.2.
Manual Hematology of Non-mammalian Species
1.2.1. Specimen Collection, Handling and
Transport to the Laboratory.
Acceptable
transport times for avian blood are shorter than that for mammalian and
reptilian blood. Controlled
studies have shown that refrigerated avian blood deteriorates within twelve
hours regardless of anticoagulant (Harr et al, 2005). Acceptable transport time
for avian blood smears on glass slides is similar to reptilian and mammalian
blood smears. Evidence of
leukocyte/thrombocyte aggregation in the hemacytometer should be reported to
indicate erroneous total WBC and differential cell counts. Hematology samples for shark species
should be processed within 5 hours (Arnold, 2005). EDTA (7.5% or 1-2 mg/mL of blood) is acceptable for most animal
species, but is not suitable for all. Blood from stingrays, some bony fishes and some avian species reacts
atypically in commercially prepared EDTA tubes. Elasmobranch blood (shark,
skates and rays) should be placed in a dry anticoagulant due to the high plasma
osmolality values (~ 1000mmol/kg). Liquid anticoagulants may be used if adjusted for osmolality.
1.2.2. Personnel Requirements.
Laboratory
personnel should have specific training in specimen handling and sample
preparation for exotic species. Training
should include basic prevention of bacterial contamination as well as
information on zoonotic diseases including Chlamydophila, West Nile Virus,
Salmonella, Avian Influenza and Giardia. Documentation of training, continuing education and periodic proficiency
assessment should be at the discretion of the laboratory director.
1.3.
Urinalysis
1.3.1. Specimen Collection, Handling and
Transport to the Laboratory.
Identification
of the urine collection method is important when interpreting the presence and
concentration of potential contaminants including blood and bacteria. The submitter should clearly state the
method by which the urine was obtained, such as free flow (midstream, early, or
late), catheterization, cystocentesis, or from the floor or metabolism
cage. Clear specimen containers
can be used to facilitate gross examination if urine will be examined within 30
minutes. However, if urinalysis
will be delayed, urine should be protected from exposure to UV light to prevent
degradation of urine constituents (eg, bilirubin). Lids should be secure to prevent evaporation and/or
volatilization of urine constituents (eg, ketones).
1.3.2. Urine Storage.
Optimally,
urine should be examined within 30 minutes of collection. If immediate examination is not
possible, urine should be stored at refrigerated temperatures to minimize
changes in urine physical and chemical make up and to inhibit bacterial
growth. Strict recommendations for
duration of refrigerated storage cannot be made, because this depends on
specific urine components. (Rabinovitch,
2009) Storage for a maximum of 24 hours
in the refrigerator is generally recommended (Osborne cautiously suggests 6-8
hours), but urine may be stable for shorter or longer periods depending on its
initial make up. Chemical
constituents that are particularly unstable include bilirubin and glucose, and
pH if bacteria are present. (Rabinovitch,
2009; Osborne, 1999) Stability of formed elements depends on
urine pH and concentration. Crystals may form in vitro during storage at either room temperature or under refrigeration. (Albasan,
2003; Sturgess, 2001) If crystalluria is a clinical concern, freshly collected
urine should be examined immediately. Refrigerated samples should be brought to
room temperature prior to analysis. Because urinalysis results may be affected by storage duration and
temperature, the time the urine was collected, the time it arrived in the
laboratory, and method of storage should be recorded. Alternative methods of preservation are available for
stabilization of urine chemistry, inhibition of bacterial growth, and
preservation of formed elements. Manufacturer's claims should be followed regarding intended use of
particular preservative and duration of storage.
1.3.3. Microbiological Culture. Quantitative microbiologic culture
techniques are recommended for determining presence of significant
bacteriuria. Urine specimens
collected by cystocentesis are preferred, but specimens properly collected by
catheterization and free-catch are acceptable if quantitative culturing methods
are employed. Urine should be submitted for the microbiological culture prior
to urinalysis procedure to avoid contamination of the specimen. Alternatively, a sterile aliquot can be
set aside for possible microbiological culture subsequent to urinalysis
procedure. Refrigerated urine
samples are acceptable for microbiological culture for at least 6 hours and
often up to 24 hours. Refrigeration of urine specimens for 24 hours may result in false
negative culture results. (Padilla, 1981) If bacteriostatic transport media is
used, urine samples do not need to be refrigerated.
1.4.
Cytology/Microbiology
1.4.1. Specimen Collection, Handling and
Transport to the Laboratory.
Information
regarding cytologic/microbiologic submissions should be provided to the client
in a laboratory service manual, special information sheet, journal or
newsletter article, written material, or verbal instructions. Instructions
should address issues such as collection techniques, appropriate containers
(with or without anticoagulants), smear preparation and specimen fixation, if
pertinent. Appropriate collection of cytologic/microbiologic specimens will
increase the likelihood of a meaningful interpretation.
1.4.2. Unfixed cytologic specimens and air-dried, unstained cytology smears
should be protected from exposure to formalin and formalin fumes, which
interfere with subsequent staining, by shipping in tightly sealed containers or
shipping separately from formalin-fixed biopsy specimens.
1.4.3. Identification of the site,
method and time of collection is of great importance in determining optimal
preparation and in interpretation. The veterinary
cytologist or cytopathologist should be knowledgeable about the effects of
different collection methods, delayed preparation and improper handling of
cytology specimens, especially fluid samples, with regard to expected cytologic
features and interpretation. For fluid samples, one or more
direct smears should be made from the fluid sample before any concentration or
fixation procedures are performed. The smear(s) can be stained or left
unstained and should be submitted with the fluid sample. This will allow estimation of the cell
count and proportions of various cell types. This may provide valuable
information that influences the cytologic interpretation and provides
additional QC by allowing the cytologist/cytopathologist to ensure that the
cell counts reasonably match estimates made from these smear(s). This also avoids the situation in which
extreme cell density of concentrated samples prevents optimal cytologic
evaluation.
1.5.
Hemostatic Testing (Coagulation)
1.5.1.
Specimen Collection, Handling and Transport to the Laboratory.
Compliance with sample collection and
storage requirements for coagulation is mandatory for accurate test results. Whole blood should be collected in
trisodium citrate anticoagulant in a 9:1 ratio and thoroughly mixed. This typically is accomplished by
filling to the indicated mark on the appropriate blood tube. Specimens that do not conform to this
dilution should be rejected. (Adcock, 1998) Citrate volume may need to be
adjusted for samples from very anemic and polycythemic animals.(Stockham and
Scott, 2008, p. 277) For tests requiring plasma, the citrated tube is centrifuged
and chilled to 2-8ºC. Plasma
should be separated from blood cells and transferred to a plastic tube (not
glass).(Fiebig, 2005, Kratz, 2006) Specimen stability at room or refrigerated temperature (2-8ºC) is 4
hours and 24 hours for APTT and PT, respectively. If testing is not performed within these time intervals,
samples should be frozen at -20 ºC. (Adcock, 1998) Fresh citrated whole blood
used for platelet function or other coagulation analyses should be ideally kept
for <1 hour. (Giger, per communication). If samples are mailed into a laboratory
for testing versus direct transport, plasma should be placed in a plastic tube
then frozen, then be packed on ice and shipped to arrive frozen within 24
hours.
1.5.2.
Please see laboratory information bulletin 1 1.5.1.A.
Additional detail was added here as >90%
of error in hemostatic assay results may be attributed to preanalytical factors
of transport and handling.(Lippi, 2006; Valenstein, 2009; Bonini, 2002; Dale,
2002)
1.6
Crossmatch
1.6.1 Specimen Collection, Handling and
Transport to the Laboratory.
Sera or plasma
may be used for crossmatching; however, the animal species and particular
procedure may influence this selection. Fresh sera could serve as a source of complement for use in detection of
hemolysis in dogs and cats, but
this is not typically performed. Samples for major crossmatch include
serum (non-additive tube) or plasma (EDTA or citrated) from recipient and
anti-coagulated (EDTA, ACD, or citrated) whole blood or packed red blood cell
sample from the donor(s). Samples
for minor crossmatch include anti-coagulated whole blood from recipient and
sera or plasma from donor(s). Patient and donor samples should be less than 24
hours old when possible; donor samples may be as old as the unit of
blood to be crossmatched. If not used immediately, samples should
be stored at 4ºC. For some
procedures, whole blood is used while others require a PBS-washed red cell
suspension. General recommendations for
sample collection, handling and transportation of hematology samples should be
followed.
1.6.2. Specimen Identification. Specimens from the patient and donor(s)
should be clearly labeled as patient and donor(s) with date and time and for
identification of the patient and each donor sample submitted. Specific
forms for submission should be considered to assure accurate assignment of
patients and donors.
1.7.
Radioimmunoassay (section left intentionally blank at this time)
Please see
Hegstad-Davies, 2006 for a review of some of the literature.